Publications
Publicaciones académicas
Los investigadores de ILGIS difunden los resultados de sus publicaciones en revistas académicas de alta calidad. Encuentra una lista de publicaciones en la siguiente sección:
Artículos en revistas académicas
Mora-García C, Pearson, A.M., Prado, A.M. (2024). “Maintaining Essential Health Services During a Pandemic: Lessons from Costa Rica’s COVID-19 Response.” British Medical Journal Global Health, 8: e014143. Online version available at https://gh.bmj.com/content/8/Suppl_6/e014143.full
Rao, D., Roberton, T., Vecino, A., Noonan, C.M., López, A., Mora-García, C., Prado, A.M., Jorge, C., Vega-Landaeta, A., Palacio-Martínez, N., Flóres, Y.N., Samuels, T.A., Metivier, C., Laptiste, C., La Foucade, A., Beharry, V., Maceira, D. (2024). “Future Health Expenditures and Its Determinants in Latin America and The Caribbean” THE LANCET Regional Health – Americas, 100781. Online version available at https://doi.org/10.1016/j.lana.2024.100781
Mora-García, C.A., Pesec, M., and Prado, A.M. (2023). “The Effect of Primary Healthcare on Mortality: Evidence from Costa Rica.” Journal of Health Economics 93:102833. Online version available at https://doi.org/10.1016/j.jhealeco.2023.102833
Pearson, A.A., Prado, A.M., and Colburn, F.D. (2021). “The Puzzle of COVID-19 in Central America and Panama.” Journal of Global Health 11. Online version available at http://jogh.org/documents/2021/jogh-11-03077.pdf
Salazar Mather, T.P., Gallo Marín, B., Medina Pérez, G., Christophers B., Paiva, M.L., Oliva, R. Hijaz, B.A., Prado, A.M., Jarquín, M.C., Moretti, K., González Marqués, C., Murillo, A., and Tobin-Tyler, E. (2020). “Love in the Time of COVID-19: Negligence in the Nicaraguan Response.” THE LANCET Global Health, 8 (6): e773. Online version available at http://doi:10.1016/s2214-109x(20)30131-5
Prado, A.M., Pearson, A.A., Bertelsen, N.S., and Pagan, J. (2020). “Building a Network of Healthcare Leaders: The Case of the Central American Healthcare Initiative (CAHI).” Globalization and Health, 16: 34-43. Online version available at https://doi.org/10.1186/s12992-020-00557-4
Capítulos en libros
“Three-Layer Health Sector Investment in Costa Rica” (Prado, A. Pearson, A., Mora, C., Guha, M., Tanugi-Carresse, A.C., Mullen, L., Bennett, S., Nuzzo, J., Maloney, J., Lazenby, S., and Liu, A.) in Strategic Investment for Health System Resilience: A Three-Layer Framework, ed. Zhao, F., Kovacevic, R., Bishai, D., and Weintraub, J. (Washington DC: World Bank, 2024).
Casos de estudio
IckIs, J. and Pearson, A., 2019, "Teensmart," Harvard Business School Publishing; the corresponding teaching note is also available. Available online at https://hbsp.harvard.edu/product/SKE175-PDF-ENG.
Pearson, A.; Selva, G., and Prado, A., 2018, "AMÓS Health and Hope," Harvard Business School Publishing; the corresponding teaching note is also available. Available online at https://hbsp.harvard.edu/product/SKE167-PDF-ENG.
Bucher, S., Jäger, U., & Prado, A. M. (2016). Scaling private health care for the base of the pyramid: Expanding versus broadening service offerings in developing nations. Journal of Business Research, 69(2), 736-750.
Prado, A. M., Calderon, D., & Zúñiga, R. (2016). Providing low-cost and high-quality medications to rural communities in developing countries: The case of Accion Medica Cristiana in Nicaragua. Journal of Business Research, 69(9), 3910-3922.
OUR RESEARCH
Maintaining essential health services during the COVID-19 pandemic
Most of Costa Rica’s public health system is overseen by a single entity, the Caja Costarricense de Seguro Social (CCSS), also known as Caja. Learn how this centralized, horizontally and vertically integrated approach to healthcare delivery enabled the country to maintain essential and emergency health services from the beginning of the COVID-19 pandemic until December 2021.
Facing the antimicrobial resistance pandemic: Current actions and future challenges in antibiotic management, access and innovation in Brazil.
While some high-income countries are considering specific actions to address the growing burden of antimicrobial resistance (AMR), efforts in low- and middle-income countries are less common. This case study analyses current efforts in Brazil, a middle-income country, to improve antibiotic stewardship, access and innovation.
